Skip to results
Modify your search
NARROW
1-20 of 31
Authors: Frédéric Laurent
Journal Article
rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 4, April 2025, Pages 1067–1071, https://doi.org/10.1093/jac/dkaf035
Published: 06 February 2025
Journal Article
EDITOR'S CHOICE
Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go? Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 11, November 2024, Pages 2742–2749, https://doi.org/10.1093/jac/dkae325
Published: 13 September 2024
Journal Article
Efficacy of ceftazidime/avibactam in various combinations for the treatment of experimental osteomyelitis in rabbits caused by OXA-48-/ESBL-producing Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1211–1218, https://doi.org/10.1093/jac/dkad070
Published: 10 March 2023
Journal Article
Linezolid resistance: detection of the cfr(B) gene in French clinical MRSA strains
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 2, February 2023, Pages 445–449, https://doi.org/10.1093/jac/dkac411
Published: 13 December 2022
Journal Article
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 9, September 2022, Pages 2532–2535, https://doi.org/10.1093/jac/dkac193
Published: 13 June 2022
Journal Article
EDITOR'S CHOICE
Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureus lineages
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 7, July 2022, Pages 1838–1846, https://doi.org/10.1093/jac/dkac119
Published: 15 April 2022
Journal Article
Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 4, April 2022, Pages 1032–1035, https://doi.org/10.1093/jac/dkab488
Published: 12 January 2022
Journal Article
In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3091–3102, https://doi.org/10.1093/jac/dkab301
Published: 30 August 2021
Journal Article
Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2863–2866, https://doi.org/10.1093/jac/dkab299
Published: 23 August 2021
Journal Article
Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 6, June 2020, Pages 1466–1473, https://doi.org/10.1093/jac/dkaa061
Published: 03 March 2020
Journal Article
Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 9, September 2019, Pages 2666–2675, https://doi.org/10.1093/jac/dkz257
Published: 01 July 2019
Journal Article
Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 7, July 2019, Pages 2060–2064, https://doi.org/10.1093/jac/dkz104
Published: 10 April 2019
Journal Article
Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 4, April 2019, Pages 1012–1020, https://doi.org/10.1093/jac/dky541
Published: 09 January 2019
Journal Article
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 625–632, https://doi.org/10.1093/jac/dky473
Published: 04 December 2018
Journal Article
European external quality assessments for identification, molecular typing and characterization of Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 10, October 2018, Pages 2662–2666, https://doi.org/10.1093/jac/dky260
Published: 07 August 2018
Journal Article
Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 10, October 2018, Pages 2901–2903, https://doi.org/10.1093/jac/dky263
Published: 27 July 2018
Journal Article
EDITOR'S CHOICE
Population pharmacokinetics and probability of target attainment of ertapenem administered by subcutaneous or intravenous route in patients with bone and joint infection
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 4, April 2018, Pages 987–994, https://doi.org/10.1093/jac/dkx477
Published: 13 December 2017
Journal Article
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 12, December 2017, Pages 3353–3356, https://doi.org/10.1093/jac/dkx314
Published: 06 September 2017
Journal Article
Pristinamycin in the treatment of MSSA bone and joint infection—authors' response
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 11, November 2016, Page 3318, https://doi.org/10.1093/jac/dkw341
Published: 01 September 2016
Journal Article
Pristinamycin in the treatment of MSSA bone and joint infection
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1063–1070, https://doi.org/10.1093/jac/dkv457
Published: 21 January 2016
